Genzyme Therapeutics Division
Executive Summary
Jan van Heek will head up newly created business unit that will have global development and marketing responsibility for the recombinant formulation of Ceredase, Thyrogen hormone, Vianain debriding agent, cystic fibrosis therapies and other products, the company announces Jan. 7. Van Heek joined the company in 1991 to set up Genzyme Therapeutics Europe...